These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 20533960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R, Doenicke A.
    Med Klin (Munich); 1993 Nov 15; 88(11):642-8. PubMed ID: 8295604
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
    Boureau F, Kappos L, Schoenen J, Esperanca P, Ashford E.
    Int J Clin Pract; 2000 Jun 15; 54(5):281-6. PubMed ID: 10954953
    [Abstract] [Full Text] [Related]

  • 9. Intravenous dihydroergotamine therapy for pediatric abdominal migraines.
    Raina M, Chelimsky G, Chelimsky T.
    Clin Pediatr (Phila); 2013 Oct 15; 52(10):918-21. PubMed ID: 23820001
    [Abstract] [Full Text] [Related]

  • 10. [Migrainous aura subtypes in hospitalized children].
    Biedroń A, Steczkowska M, Zajac A, Stolarska U, Kroczka S.
    Przegl Lek; 2009 Oct 15; 66(11):952-7. PubMed ID: 20297637
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exacerbation of SUNCT and SUNA syndromes during intravenous dihydroergotamine treatment: A case series.
    Lambru G, Shanahan P, Matharu M.
    Cephalalgia; 2015 Oct 15; 35(12):1115-24. PubMed ID: 25667300
    [Abstract] [Full Text] [Related]

  • 14. Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
    Theroux LM, Cappa R, Mendoza A, Mallawaarachchi I, Samanta D, Goodkin HP.
    Headache; 2020 Sep 15; 60(8):1653-1663. PubMed ID: 32853454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.
    Smith TR, Winner P, Aurora SK, Jeleva M, Hocevar-Trnka J, Shrewsbury SB.
    Headache; 2021 Sep 15; 61(8):1214-1226. PubMed ID: 34363701
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of transformed refractory migraine with intravenous dihydroergotamine].
    Cid C, Ortega-Valín F, Valero M, Muñoz R, Pascual J.
    Neurologia; 1999 Sep 15; 14(6):315-8. PubMed ID: 10439626
    [Abstract] [Full Text] [Related]

  • 18. Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review.
    Fisher M, Gosy EJ, Heary B, Shaw D.
    Curr Med Res Opin; 2007 Apr 15; 23(4):751-5. PubMed ID: 17407631
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT.
    Headache; 1997 Apr 15; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.